Literature DB >> 2230836

The fate of Schwann cell basement membranes in permanently transected nerves.

C Giannini1, P J Dyck.   

Abstract

After peripheral nerve fiber degeneration, Schwann cell basement membranes (SCBM) persist, maintain the columnar orientation of multiplying Schwann cells, and provide pathways for regenerating axons to original target tissue. Despite the putative importance of these functions, there is little quantitative information on SCBM in chronic denervation. The number, integrity, shape, and size of SCBM were evaluated in transverse electron micrographs of peroneal nerves of groups of mice at various times after permanent sciatic nerve transection. With increasing time after transection, the SCBM fragment, the fragments become shorter, dispersed throughout the endoneurium and partially disappear. The discontinuity, dispersion, and partial disappearance of SCBM, which worsens with time after nerve transection, alters the scaffold by which neurites grow back to formerly innervated or appropriate target tissue. Without reaching appropriate target tissue, regenerating fibers may fail to develop or undergo retrograde atrophy and degeneration. The progressive changes of the SCBM may contribute to the demonstrated poor regeneration when nerve reconnection is delayed, or when proximal nerves are reconnected, so that much time may elapse before neurites grow back to distal nerve.

Entities:  

Mesh:

Year:  1990        PMID: 2230836     DOI: 10.1097/00005072-199011000-00002

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  18 in total

1.  Factors contributing to preferential motor reinnervation in the primate peripheral nervous system.

Authors:  R D Madison; S J Archibald; R Lacin; C Krarup
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

2.  Motor and sensory re-innervation of the lung and heart after re-anastomosis of the cervical vagus nerve in rats.

Authors:  Fabienne Bregeon; Jean Roch Alliez; Géraldine Héry; Tanguy Marqueste; Sylvie Ravailhe; Yves Jammes
Journal:  J Physiol       Date:  2007-04-12       Impact factor: 5.182

3.  The effects of delayed nerve repair on neuronal survival and axonal regeneration after seventh cervical spinal nerve axotomy in adult rats.

Authors:  Sharmila Jivan; Liudmila N Novikova; Mikael Wiberg; Lev N Novikov
Journal:  Exp Brain Res       Date:  2005-11-19       Impact factor: 1.972

4.  Chondroitinase treatment increases the effective length of acellular nerve grafts.

Authors:  Debbie Neubauer; James B Graham; David Muir
Journal:  Exp Neurol       Date:  2007-06-23       Impact factor: 5.330

5.  Axonal regeneration into chronically denervated distal stump. 2. Active expression of type I collagen mRNA in epineurium.

Authors:  J Siironen; V Vuorinen; H S Taskinen; M Röyttä
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

6.  The dynamics of beta 1 integrin expression during peripheral nerve regeneration.

Authors:  H S Taskinen; J Heino; M Röyttä
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

7.  Neural architecture in transected rabbit sciatic nerve after prolonged nonreinnervation.

Authors:  J L Bradley; D A Abernethy; R H King; J R Muddle; P K Thomas
Journal:  J Anat       Date:  1998-05       Impact factor: 2.610

Review 8.  The cellular and molecular basis of peripheral nerve regeneration.

Authors:  S Y Fu; T Gordon
Journal:  Mol Neurobiol       Date:  1997 Feb-Apr       Impact factor: 5.590

9.  Design of super-elastic biodegradable scaffolds with longitudinally oriented microchannels and optimization of the channel size for Schwann cell migration.

Authors:  Koichiro Uto; Takanari Muroya; Michio Okamoto; Hiroyuki Tanaka; Tsuyoshi Murase; Mitsuhiro Ebara; Takao Aoyagi
Journal:  Sci Technol Adv Mater       Date:  2012-11-23       Impact factor: 8.090

10.  [Paralyzed face. Ansa-cervicalis-nervi-hypoglossi].

Authors:  J Schipper; S Arndt; W Maier; U Spetzger; G J Ridder
Journal:  Chirurg       Date:  2005-01       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.